Trivarx Ltd has released a press release.
FDA Confirm Diagnostic Method on Depression Validation Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Medibio Announces Entitlement Offer Result
- Termination of Underwriting Agreement
- Non-Renounceable Entitlement Offer Underwriting Update
- MEB to Raise up to $5.7 million by way of a Placement & NREO
- FDA Strategy and Regulatory Update
Later from TrivarX
- Voluntary Suspension
- Reinstatement to Quotation
- MEB to Raise $1.4m by way of a Placement & MD/CEO Resigns
- Sleep Analysis Depressive Burden Study Clinical Trial
- Appendix 4E and Preliminary Final Report
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX